Saline solution ("B") — Competitive Intelligence Brief

Saline solution ("B") (Saline solution ("B")) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution / Fluid replacement. Area: General supportive care / Fluid and electrolyte management.

marketed Electrolyte solution / Fluid replacement General supportive care / Fluid and electrolyte management Small molecule

Target snapshot

Saline solution ("B") (Saline solution ("B")) — Hospital Universitari de Bellvitge. Saline solution provides electrolyte and fluid replacement by delivering sodium chloride and water to restore osmotic balance and hydration status.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Saline solution ("B") TARGET	Saline solution ("B")	Hospital Universitari de Bellvitge	marketed	Electrolyte solution / Fluid replacement
saline infusion	saline infusion	University Hospital, Linkoeping	marketed	Electrolyte solution / Fluid replacement
IN saline 0.9%	IN saline 0.9%	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	phase 3	Electrolyte solution / Fluid replacement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution / Fluid replacement class)

1. Hospital Universitari de Bellvitge · 1 drug in this class
2. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
3. University Hospital, Linkoeping · 1 drug in this class